This month Rick rants about medications for such diseases as hepatitis C and diabetes, that are priced so that poor people cannot afford them and, as such, disproportionately place these people at risk for death.
That markup to 84,000 is just laughable, but mainly sad. I don't know how those executives sleep at night (on their Egyptian cotton sheets). Hopefully NEMPAC is tackling this as one of their main issues, along with drug shortages
EMA 2018 NovemberFull episode audio for MD edition244:25 min - 61 MB - M4AEMA 2018 November All Abstracts PDF7 MB - PDFEMA 2018 November Individual Abstracts Zip File5 MB - ZIPEMA 2018 November Individual MP3s476 MB - ZIPEMA 2018 November - Printable CME Questions48 KB - PDFEMA Citations - November 2018505 KB - PDFTime To Talk A Little Nerdy: Pneumonia Care Controversies237 KB - PDF
Steve D. - November 14, 2018 9:52 PM
That markup to 84,000 is just laughable, but mainly sad. I don't know how those executives sleep at night (on their Egyptian cotton sheets). Hopefully NEMPAC is tackling this as one of their main issues, along with drug shortages
W. Richard B. - November 16, 2018 2:06 PM
Seems that you could take an empty suitcase to India, fill it with the hep C pills and come back to the states and sell them for $100 each and retire.